A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)

Clinical trial NCT07501559 · RECRUITING

Trial details

NCT number: NCT07501559
Sponsor: Jecho Biopharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Glioblastoma Multiforme(GBM)

Start date: 2026-06-17
Primary completion: 2030-04-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.